4th Global Congress on Sickle Cell Disease
Join Biomaneo & Shimadzu at the 4th Global Congress on Sickle Cell Disease taking place in Paris from June 16-18.
Biomaneo obtains ISO 13485:2016 certification and strengthens its quality team
A key step for the marketing of its In Vitro Diagnostic Devices (IVDD) and in the transition to the new 2017/746 regulation.
New NeoSickle installation
With this second installation, 80% of French samples are now analysed using the NeoSickle solution.
Biomaneo puts the spotlight on the training of young people...
By welcoming three new employees to its teams